Microdiol

Desogestrel/Ethinylestradiol, the active ingredient in Microdiol, is a combined oral contraceptive presented as a tablet for oral use. It works to prevent pregnancy in women of reproductive age by inhibiting ovulation, thickening cervical mucus, and altering the endometrium.

GNH USA supplies Microdiol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to EU regulatory standards and is manufactured under strict quality controls.

Microdiol is a combined oral contraceptive that acts on the hormonal regulation of the menstrual cycle. - Contraception (prevention of pregnancy): provides reliable birth control for women of reproductive age. - Menstrual cycle regulation: helps establish a more predictable menstrual pattern. - Treatment of moderate acne: reduces androgen‑driven skin lesions in eligible patients.

Microdiol may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: temporary swelling or discomfort. - Spotting or breakthrough bleeding: irregular light bleeding. - Weight gain: modest fluid retention. - Mood changes: irritability or mild depression.

Serious or Rare Side Effects: - Venous thromboembolism: deep‑vein thrombosis or pulmonary embolism. - Arterial thrombosis: stroke or myocardial infarction. - Severe hypertension: sudden increase in blood pressure. - Liver dysfunction: jaundice or abnormal liver enzymes. - Gallbladder disease: cholelithiasis or cholecystitis. - Allergic reaction: rash, swelling, or anaphylaxis.

Before prescribing Microdiol, clinicians should evaluate individual risk factors and contraindications. - Smoking: avoid use in women over 35 who smoke due to increased cardiovascular risk. - History of thromboembolism: contraindicated in patients with prior clotting events. - Hypertension: monitor blood pressure regularly. - Liver disease: use with caution in patients with active liver pathology. - Migraine with aura: consider alternative contraception. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Microdiol can interact with several medicines that affect hormone metabolism or clotting risk.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine): markedly reduce contraceptive efficacy. - Anticoagulants (e.g., warfarin): may increase bleeding risk. - Certain antiretrovirals (e.g., protease inhibitors): can alter hormone levels.

Moderate Interactions (Monitor Closely): - Antifungals (e.g., ketoconazole): may increase hormone concentrations. - Antidepressants (e.g., sertraline): potential for modest pharmacokinetic changes. - Herbal supplements (e.g., St John’s wort): may reduce effectiveness. - Diuretics: may affect fluid balance and blood pressure.